238 related articles for article (PubMed ID: 24102621)
1. Caspase cleavage of GFAP produces an assembly-compromised proteolytic fragment that promotes filament aggregation.
Chen MH; Hagemann TL; Quinlan RA; Messing A; Perng MD
ASN Neuro; 2013 Nov; 5(5):e00125. PubMed ID: 24102621
[TBL] [Abstract][Full Text] [Related]
2. The Alexander disease-causing glial fibrillary acidic protein mutant, R416W, accumulates into Rosenthal fibers by a pathway that involves filament aggregation and the association of alpha B-crystallin and HSP27.
Der Perng M; Su M; Wen SF; Li R; Gibbon T; Prescott AR; Brenner M; Quinlan RA
Am J Hum Genet; 2006 Aug; 79(2):197-213. PubMed ID: 16826512
[TBL] [Abstract][Full Text] [Related]
3. Site-specific phosphorylation and caspase cleavage of GFAP are new markers of Alexander disease severity.
Battaglia RA; Beltran AS; Delic S; Dumitru R; Robinson JA; Kabiraj P; Herring LE; Madden VJ; Ravinder N; Willems E; Newman RA; Quinlan RA; Goldman JE; Perng MD; Inagaki M; Snider NT
Elife; 2019 Nov; 8():. PubMed ID: 31682229
[TBL] [Abstract][Full Text] [Related]
4. Alexander disease causing mutations in the C-terminal domain of GFAP are deleterious both to assembly and network formation with the potential to both activate caspase 3 and decrease cell viability.
Chen YS; Lim SC; Chen MH; Quinlan RA; Perng MD
Exp Cell Res; 2011 Oct; 317(16):2252-66. PubMed ID: 21756903
[TBL] [Abstract][Full Text] [Related]
5. Elevated GFAP isoform expression promotes protein aggregation and compromises astrocyte function.
Lin NH; Yang AW; Chang CH; Perng MD
FASEB J; 2021 May; 35(5):e21614. PubMed ID: 33908669
[TBL] [Abstract][Full Text] [Related]
6. Plectin regulates the organization of glial fibrillary acidic protein in Alexander disease.
Tian R; Gregor M; Wiche G; Goldman JE
Am J Pathol; 2006 Mar; 168(3):888-97. PubMed ID: 16507904
[TBL] [Abstract][Full Text] [Related]
7. Effects of Alexander disease-associated mutations on the assembly and organization of GFAP intermediate filaments.
Yang AW; Lin NH; Yeh TH; Snider N; Perng MD
Mol Biol Cell; 2022 Jul; 33(8):ar69. PubMed ID: 35511821
[TBL] [Abstract][Full Text] [Related]
8. Alexander-disease mutation of GFAP causes filament disorganization and decreased solubility of GFAP.
Hsiao VC; Tian R; Long H; Der Perng M; Brenner M; Quinlan RA; Goldman JE
J Cell Sci; 2005 May; 118(Pt 9):2057-65. PubMed ID: 15840648
[TBL] [Abstract][Full Text] [Related]
9. Murine model of Alexander disease: analysis of GFAP aggregate formation and its pathological significance.
Tanaka KF; Takebayashi H; Yamazaki Y; Ono K; Naruse M; Iwasato T; Itohara S; Kato H; Ikenaka K
Glia; 2007 Apr; 55(6):617-31. PubMed ID: 17299771
[TBL] [Abstract][Full Text] [Related]
10. Glial fibrillary acidic protein filaments can tolerate the incorporation of assembly-compromised GFAP-delta, but with consequences for filament organization and alphaB-crystallin association.
Perng MD; Wen SF; Gibbon T; Middeldorp J; Sluijs J; Hol EM; Quinlan RA
Mol Biol Cell; 2008 Oct; 19(10):4521-33. PubMed ID: 18685083
[TBL] [Abstract][Full Text] [Related]
11. Dynamics of mutated GFAP aggregates revealed by real-time imaging of an astrocyte model of Alexander disease.
Mignot C; Delarasse C; Escaich S; Della Gaspera B; Noé E; Colucci-Guyon E; Babinet C; Pekny M; Vicart P; Boespflug-Tanguy O; Dautigny A; Rodriguez D; Pham-Dinh D
Exp Cell Res; 2007 Aug; 313(13):2766-79. PubMed ID: 17604020
[TBL] [Abstract][Full Text] [Related]
12. Caspase proteolysis of desmin produces a dominant-negative inhibitor of intermediate filaments and promotes apoptosis.
Chen F; Chang R; Trivedi M; Capetanaki Y; Cryns VL
J Biol Chem; 2003 Feb; 278(9):6848-53. PubMed ID: 12477713
[TBL] [Abstract][Full Text] [Related]
13. GFAP mutations in Alexander disease.
Li R; Messing A; Goldman JE; Brenner M
Int J Dev Neurosci; 2002; 20(3-5):259-68. PubMed ID: 12175861
[TBL] [Abstract][Full Text] [Related]
14. Glial fibrillary acidic protein exhibits altered turnover kinetics in a mouse model of Alexander disease.
Moody LR; Barrett-Wilt GA; Sussman MR; Messing A
J Biol Chem; 2017 Apr; 292(14):5814-5824. PubMed ID: 28223355
[TBL] [Abstract][Full Text] [Related]
15. Aggregation-prone GFAP mutation in Alexander disease validated using a zebrafish model.
Lee SH; Nam TS; Kim KH; Kim JH; Yoon W; Heo SH; Kim MJ; Shin BA; Perng MD; Choy HE; Jo J; Kim MK; Choi SY
BMC Neurol; 2017 Sep; 17(1):175. PubMed ID: 28882119
[TBL] [Abstract][Full Text] [Related]
16. Relative stabilities of wild-type and mutant glial fibrillary acidic protein in patients with Alexander disease.
Heaven MR; Wilson L; Barnes S; Brenner M
J Biol Chem; 2019 Oct; 294(43):15604-15612. PubMed ID: 31484723
[TBL] [Abstract][Full Text] [Related]
17. Alexander disease-associated glial fibrillary acidic protein mutations in mice induce Rosenthal fiber formation and a white matter stress response.
Hagemann TL; Connor JX; Messing A
J Neurosci; 2006 Oct; 26(43):11162-73. PubMed ID: 17065456
[TBL] [Abstract][Full Text] [Related]
18. STAT3 Drives GFAP Accumulation and Astrocyte Pathology in a Mouse Model of Alexander Disease.
Hagemann TL; Coyne S; Levin A; Wang L; Feany MB; Messing A
Cells; 2023 Mar; 12(7):. PubMed ID: 37048051
[TBL] [Abstract][Full Text] [Related]
19. Properties of astrocytes cultured from GFAP over-expressing and GFAP mutant mice.
Cho W; Messing A
Exp Cell Res; 2009 Apr; 315(7):1260-72. PubMed ID: 19146851
[TBL] [Abstract][Full Text] [Related]
20. Autophagy induced by Alexander disease-mutant GFAP accumulation is regulated by p38/MAPK and mTOR signaling pathways.
Tang G; Yue Z; Talloczy Z; Hagemann T; Cho W; Messing A; Sulzer DL; Goldman JE
Hum Mol Genet; 2008 Jun; 17(11):1540-55. PubMed ID: 18276609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]